Skip to content
★ Sign in to follow
WP
Total declarations
21
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€611k

Latest filing published 16 Nov 2017 for HAEMONETICS CORP, €329k.

Filing timeline

BuySale
Willaim P. Burke

Insider track record

Disclosed buys
0
Disclosed sells
18
Signal history

Willaim P. Burke: trading record in brief

Willaim P. Burke discloses dealings in Haemonetics Corp to SEC (Form 4). Over a trading history stretching from 25 October 2016 to 14 November 2017, the count stands at 21 filings.

Every open-market trade on record is a sale: 18 sales worth €611k. Other entries cover 2 share grants and 1 option exercise. In 2017 alone, the filings show no purchases and 18 sales.

The latest filing, published on 16 November 2017, reports an open-market sale of €7,547 in Haemonetics Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Willaim P. Burke

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ◇
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    384,213 USD21SEC
    11,231 shares@ US$34.2122.5% of flowCommon StockSEC:0001127602-17-032439:0
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    535,086 USD37SEC
    9,909 shares@ US$54.0031.3% of flowCommon StockSEC:0001127602-17-032439:1
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    60,599 USD34SEC
    1,122 shares@ US$54.013.5% of flowCommon StockSEC:0001127602-17-032439:2
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,403 USD34SEC
    100 shares@ US$54.030.3% of flowCommon StockSEC:0001127602-17-032439:3
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,404 USD34SEC
    100 shares@ US$54.040.3% of flowCommon StockSEC:0001127602-17-032439:4
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    10,820 USD34SEC
    200 shares@ US$54.100.6% of flowCommon StockSEC:0001127602-17-032439:5
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    10,858 USD34SEC
    200 shares@ US$54.290.6% of flowCommon StockSEC:0001127602-17-032439:6
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    10,830 USD34SEC
    200 shares@ US$54.150.6% of flowCommon StockSEC:0001127602-17-032439:7
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,416 USD34SEC
    100 shares@ US$54.160.3% of flowCommon StockSEC:0001127602-17-032439:8
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,417 USD34SEC
    100 shares@ US$54.170.3% of flowCommon StockSEC:0001127602-17-032439:9
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,419 USD34SEC
    100 shares@ US$54.190.3% of flowCommon StockSEC:0001127602-17-032439:10
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    2,114 USD34SEC
    39 shares@ US$54.200.1% of flowCommon StockSEC:0001127602-17-032439:11
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    8,728 USD34SEC
    161 shares@ US$54.210.5% of flowCommon StockSEC:0001127602-17-032439:12
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,423 USD34SEC
    100 shares@ US$54.230.3% of flowCommon StockSEC:0001127602-17-032439:13
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,428 USD34SEC
    100 shares@ US$54.280.3% of flowCommon StockSEC:0001127602-17-032439:14
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    10,862 USD34SEC
    200 shares@ US$54.310.6% of flowCommon StockSEC:0001127602-17-032439:16
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    5,433 USD34SEC
    100 shares@ US$54.330.3% of flowCommon StockSEC:0001127602-17-032439:17
  • ▼
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    8,803 USD34SEC
    162 shares@ US$54.340.5% of flowCommon StockSEC:0001127602-17-032439:18
  • ◆
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    232,476 USD20SEC
    5,583 shares@ US$41.6414.1% of flowCommon StockSEC:0001127602-17-020971:0
  • ◆
    EVP, Chief Financial OfficerExecutivesHaemonetics Corp
    356,229 USD21SEC
    10,413 shares@ US$34.2122.3% of flowCommon StockSEC:0001127602-16-065405:0

20 of 20 declarations